NEW YORK (GenomeWeb) – Aegis Sciences has acquired molecular diagnostics firm Diagnovus for an undisclosed amount, the companies said today.

Diagnovus, based in Nashville, Tenn., has developed a suite of oncology and gastroenterology tests using a range of technologies, including PCR, next-generation sequencing, and gene expression analysis. In addition, it offers clinical trial, bioinformatics, and other clinical services on a variety of technology platforms.

Aegis, also based in Nashville, is a toxicology laboratory that specializes in forensic and healthcare services.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.